AU Patent

AU2016224930A1 — Process for the preparation of Vortioxetine

Assigned to Lupin Ltd · Expires 2017-09-07 · 9y expired

What this patent protects

Disclosed herein a process for the isolation of intermediate of Vortioxetine in a solid state form and an improved, commercially viable and industrially advantageous process for the preparation of vortioxetine or a pharmaceutically acceptable salt thereof, in high yield and purit…

USPTO Abstract

Disclosed herein a process for the isolation of intermediate of Vortioxetine in a solid state form and an improved, commercially viable and industrially advantageous process for the preparation of vortioxetine or a pharmaceutically acceptable salt thereof, in high yield and purity.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016224930A1
Jurisdiction
AU
Classification
—
Expires
2017-09-07
Drug substance claim
No
Drug product claim
No
Assignee
Lupin Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.